Skip to main content

Table 1 Descriptive data of the two groups

From: Extracorporeal shockwave therapy versus musculoskeletal mesotherapy for Achilles tendinopathy in athlete

Variant

Group I (ESWT)

Group II (mesotherapy)

χ2*

P

S

Sex (M/F) (N/%)

16(80%)/4(20%)

15(75%)/5(25%)

0.000

1.000

NS

Age (years) range

  

0.241 t

0.811

NS

Mean ± SD

18–39

19–38

   

35.9 ± 5.4

34.7 ± 6.1

Duration (months)

  

0.295 t

0.769

NS

Range

     

Mean ± SD

5.2 ± 3.5

4.9 ± 2.9

   

Type of tendinopathy

Insertional/non-insertionalN(%)

11 (55%)/9 (45%)

12 (60%)/8 (40%)

0.000

1.000

NS

  1. M male, F female, NS non-significant
  2. *Chi-square, t; Student’s t